Article
PARP inhibitor olaparib induces DNA damage and acts as a drug sensitizer in an in vitro model of canine hematopoietic cancer
2025-04-17
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold> The introduction of genetic tests based on next-generation sequencing techniques into veterinary cancer diagnostics provides information on molecularly targeted therapies useful for dogs. However, there is still a lack of in vitro studies describing the effect and mechanism of action of such anticancer drugs in companion animals. Our study aimed to demonstrate in...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8034412c-d0b7-50d6-b034-4a9d76029de9
- DOI
- 10.21203/rs.3.rs-6148132/v1
